Hence, studies have shown that combination therapy using MDM2/MDMX inhibitors result in a more effective anti-tumor reaction by more actively inducing apoptosis and cancer cell cycle arrest (81, 101, 104). The gene discussed is MDM2; the disease is neoplasm.